Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia.

Sci Rep · 2021 · PMC7854679 · PMID 33531590

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

near-significantP ≤ 0.1so close (0.05 < p ≤ 0.1)

In our independent validation cohort (12 JMML patients and 6 PN), significant and near-significant (P ≤ 0.1) overexpression was confirmed for 10 and 4 lncRNAs respectively (31%) (Supplemental Figure S1 ).

also in 2,306 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.